Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Stars Tech Co. Ltd. is managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner and 1 distinct art unit, keeping the current prosecution focused in one area. This concentration in 1 distinct art unit indicates that the company's active patent matters are technically aligned. Managing 1 pending office action allows for a streamlined administrative process with a single examiner to communicate with.
TSAY, MARSHA M is the busiest examiner with 1 busiest examiner pending office action. This examiner manages the total 1 pending office action for the portfolio, acting as the sole reviewer for the company's active matters. Because the busiest examiner pending count is 1, matching the total number of pending office actions, the company's current success at the patent office depends on this single individual. There are no other distinct examiners or art units currently active, so practitioners should focus on the specific examination patterns of TSAY, MARSHA M.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TSAY, MARSHA M | 1 | 45.5% | +52.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17798681 | METHOD FOR OBTAINING COLLAGEN PEPTIDE FROM STARFISH, ELASTIC LIPOSOME COMPRISING STARFISH-DERIVED COLLAGEN PEPTIDE, AND COSMETIC COMPOSITION COMPRISING SAME | TSAY, MARSHA M | 29d |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17798681 | METHOD FOR OBTAINING COLLAGEN PEPTIDE FROM STARFISH, ELASTIC LIPOSOME COMPRISING STARFISH-DERIVED COLLAGEN PEPTIDE, AND COSMETIC COMPOSITION COMPRISING SAME | TSAY, MARSHA M | 1656 | §103 | Non-Final OA | 29d | Pending | Aug 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialStars Tech Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Marsha M Tsay has the most, with 1 of Stars Tech Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
